N2Kool - you write well but help me understand why a stronger dollar makes ELTP more attractive for a foreign pharma? The opposite would seem to be the case, no?
- 3,5bn upon FILING is absolute bonkers. Filing does not equal approval. With Nas's timeline we would then see a more than 20x increase in PPS in the next 8 months. How can any acquiring company defend that in front of their shareholders?